PTHS vs VRCA
Comparison between Channel Therapeutics Corporation (PTHS, Company) and Verrica Pharmaceuticals Inc (VRCA, Company).
Both PTHS and VRCA are from the Healthcare sector.
PTHS vs VRCA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
PTHS
$98M
VRCA
$97M
Max Drawdown
Winner
PTHS
88.73%
VRCA
98.39%
Sharpe Ratio
Winner
PTHS
1.20
VRCA
0.30
5Y Beta
PTHS
1.13
Winner
VRCA
0.58
Industry
PTHS
Biotechnology
VRCA
Biotechnology
P/E Ratio
PTHS
-0.74
Winner
VRCA
-5.41
PEG Ratio
PTHS
-0.00
VRCA
N/A
Debt to Equity
PTHS
0.00%
VRCA
0.00%
Free Cash Flow Yield
PTHS
-36.20%
Winner
VRCA
-14.59%
PTHS vs VRCA - Historical Returns
Returns include dividend reinvestment.
1M
Winner
PTHS
+10.90%
VRCA
-4.09%
3M
Winner
PTHS
+20.43%
VRCA
-1.40%
6M
Winner
PTHS
+27.92%
VRCA
-30.58%
1Y
Winner
PTHS
+141.67%
VRCA
-2.73%
5Y(CAGR)
PTHS
N/A
VRCA
-45.37%
10Y(CAGR)
PTHS
N/A
VRCA
-34.89%
Max(CAGR)
Winner
PTHS
-19.41%
VRCA
-34.89%
PTHS vs VRCA - Annual Returns (2018 - 2026)
Returns include dividend reinvestment.
| Year | PTHS | VRCA |
|---|---|---|
| 2026 | -1.53% | -32.17% |
| 2025 | +328.54% | +18.27% |
| 2024 | -86.65% | -89.72% |
| 2023 | N/A | +154.17% |
| 2022 | N/A | -71.02% |
| 2021 | N/A | -23.92% |
| 2020 | N/A | -24.57% |
| 2019 | N/A | +99.87% |
| 2018 | N/A | -53.43% |
PTHS vs VRCA Drawdown Comparison
The maximum drawdown for PTHS was -88.73%, occurring on Nov 19, 2024. This drawdown has not yet recovered.
The maximum drawdown for VRCA was -98.39%, occurring on Nov 4, 2025. This drawdown has not yet recovered.
The current PTHS drawdown is -39.58%. The current VRCA drawdown is -97.23%.
| Rank | PTHS | VRCA |
|---|---|---|
| #1 | -88.73% Feb 16, 2024 - Nov 19, 2024 | -98.39% Jun 25, 2018 - Nov 4, 2025 |
| #2 | N/A | -1.04% Jun 20, 2018 - Jun 25, 2018 |
Correlation
Correlation between PTHS and VRCA is -0.11 which considered as a very weak or no correlation - the stocks move independently of each other.
-0.11
-101
Select Stocks to Compare
Popular: PTHS vs SPYVRCA vs SPY
More Comparisons
Compare with similar stocks